Evenamide
CAS No. 1092977-61-1
Evenamide( NW-3509 )
Catalog No. M23295 CAS No. 1092977-61-1
Evenamide is a sodium channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 85 | In Stock |
|
| 5MG | 77 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 250 | In Stock |
|
| 50MG | 390 | In Stock |
|
| 100MG | 631 | In Stock |
|
| 200MG | 879 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEvenamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionEvenamide is a sodium channel blocker.
-
DescriptionEvenamide is a sodium channel blocker. Which shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness.
-
In VitroEvenamide selectively blocks voltage-gated sodium channels (VGSCs) in a voltage-and use-dependent manner (Ki=0.4 μM) and modulates sustained repetitive firing without inducing impairment of the normal neuronal excitability. Evenamide does not bind, inhibit or interact with over 130 receptors, enzymes, or transporters.
-
In VivoEvenamide is active in a wide range of psychiatric animal models in monotherapy and addon to antipsychotics. Evenamide is effective in attenuating the social interaction deficit in Cl 395 (PCP)-impaired rats (MED=1 mg/kg po).
-
SynonymsNW-3509
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1092977-61-1
-
Formula Weight278.39
-
Molecular FormulaC16H26N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:290 mg/mL (1041.70 mM; Need ultrasonic)
-
SMILESCCCCOc1cccc(CCNCC(N(C)C)=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Valentina Zuliani, et al. Advances in Design and Development of Sodium Channel Blockers. Ion Channels and Their Inhibitors pp 79-115.
molnova catalog
related products
-
Bupivacaine
Bupivacaine (AH-250) is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.
-
Levobupivacaine
Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide.
-
R 56865
R 56865 is a weak potential-operated channel inhibitor that inhibits the late sodium current in human isolated cardiomyocytes.
Cart
sales@molnova.com